Dana Investment Advisors Inc. reduced its stake in ProAssurance Co. (NYSE:PRA - Free Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 409,949 shares of the insurance provider's stock after selling 23,571 shares during the quarter. Dana Investment Advisors Inc. owned about 0.80% of ProAssurance worth $6,522,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Zacks Investment Management acquired a new stake in shares of ProAssurance during the 3rd quarter worth about $5,140,000. Wellington Management Group LLP lifted its stake in shares of ProAssurance by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,164,085 shares of the insurance provider's stock valued at $47,588,000 after buying an additional 91,987 shares during the period. JPMorgan Chase & Co. boosted its position in ProAssurance by 34.8% during the third quarter. JPMorgan Chase & Co. now owns 253,175 shares of the insurance provider's stock worth $3,808,000 after acquiring an additional 65,325 shares during the last quarter. Wakefield Asset Management LLLP acquired a new stake in ProAssurance during the fourth quarter worth approximately $1,036,000. Finally, Barclays PLC grew its stake in ProAssurance by 307.5% in the 3rd quarter. Barclays PLC now owns 85,117 shares of the insurance provider's stock worth $1,280,000 after acquiring an additional 64,228 shares during the period. Institutional investors and hedge funds own 85.58% of the company's stock.
ProAssurance Trading Down 0.9 %
Shares of NYSE PRA traded down $0.13 during trading on Monday, hitting $15.25. 312,762 shares of the company traded hands, compared to its average volume of 251,482. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $779.99 million, a P/E ratio of 18.37 and a beta of 0.21. The company has a 50-day moving average price of $15.09 and a 200-day moving average price of $15.17. ProAssurance Co. has a 1 year low of $10.76 and a 1 year high of $17.79.
ProAssurance (NYSE:PRA - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.19. The firm had revenue of $287.52 million during the quarter, compared to the consensus estimate of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. On average, equities analysts predict that ProAssurance Co. will post 0.8 EPS for the current year.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on PRA shares. Truist Financial raised their price objective on ProAssurance from $14.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, November 12th. StockNews.com upgraded ProAssurance from a "hold" rating to a "buy" rating in a research report on Thursday. Finally, Piper Sandler cut ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 price target for the company. in a report on Monday, November 11th.
Read Our Latest Stock Report on PRA
ProAssurance Company Profile
(
Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Articles

Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.